Rate Of Adverse Reactions To COVID Vaccines Already 50x

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
217
Rate Of Adverse Reactions To COVID Vaccines Already 50x Higher Than Flu Shot

With reports this morning of another otherwise-healthy patient dying suddenly after receiving her first dose of a COVID-19 vaccine, many skeptics in both Europe and the US still have serious reservations about the jabs, even as big pharma and their allies in the US and British governments insist that they are 100% safe. Everyone claiming otherwise is not only wrongheaded, but acting in a deliberately malicious manner.

s new questions about efficacy and timing arise, independent journalist Alex Berenson, one of the most prominent skeptics of lockdowns and masks in the US, noted in a twitter thread earlier on Tuesday that the percentage of patients experiencing severe or potentially life-threatening reactions to the COVID-19 vaccines could be much higher than the data collected by the CDC are letting on.

The CDC's VAERS reporting system was set up to track vaccine-related injury, Most patients can expect to experience some kind of adverse reaction, but for the vast majority of patients, symptoms will be relatively mild and clear up within a couple of days. But amid a rush of reports about patient deaths, Berenson points out that the number of patients seeing serious complications per the number of doses distributed is roughly 50x higher than the rate of 'adverse' reactions caused by the flu vaccine.

1/ Through Dec. 22, with fewer than 1 million doses of the #Covid vaccine given, @cdcgov's vaccine injury reporting system received 307 reports of ER visits and 17 "life threatening" events.

Per dose, that's roughly 50 times the rate of adverse events from the flu vaccine...

— Alex Berenson (@AlexBerenson) January 5, 2021
2/ In 2019-2020, about 175 million flu vaccine doses were given. 1220 ER visits and 73 "life threatening" events were reported. The data is on the CDC VAERS Website.

Caveats: physicians et al may be more diligent about reporting #Covid vaccine events, since the vaccine is new...

— Alex Berenson (@AlexBerenson) January 5, 2021
3/ And the data is theoretically updated through Friday Jan. 1, which would be a much higher denominator. However, I believe it is correct to use Dec. 22 as the last date for Covid adverse events because I cannot find any later reports in the system...

— Alex Berenson (@AlexBerenson) January 5, 2021
Berenson also speculated that this number might be even higher due to possible delays in updating the CDC's data sets. This would seemingly confirm rates of adverse reactions seen during clinical trials. What's more, clinical trials, generally speaking, tend to "UNDERSTATE" unpleasant or unwanted side effects, while they "OVERSTATE" the drug's efficacy.

4/ Plus, the first Covid vaccine doses have mostly been given to healthy people in settings where problems can be quickly treated. These problems are occurring BEFORE the rollout to older, less healthy people - and before the 2nd dose, which is known to be far more dangerous...

— Alex Berenson (@AlexBerenson) January 5, 2021
5/ And this merely confirms what the clinical trials showed (in general, though not always, clinical trials tend to UNDERSTATE real world problems and OVERSTATE efficacy, because any smart drug company will try to bias the trials in its favor).

— Alex Berenson (@AlexBerenson) January 5, 2021
For readers who are so inclined, Berenson shared a link to the CDC data, which isn't exactly easy to find on the agency's website.

The data is here, and fairly straightforward to query.https://t.co/qOp5zS7cYB

— Alex Berenson (@AlexBerenson) January 5, 2021
Meanwhile, the US, UK and Europe are all lagging behind vaccination targets, while Russian President Vladimir Putin recently suggested that Russia might jump on the "Immunity Passport" bandwagon.

Berenson recently sat for an interview with Joe Rogan on Rogan's popular podcast, where the longtime journalist discussed other misconceptions about the "science" behind COVID-19, including questioning the US death toll.

[YT]goZQ6iOIFYo[/YT]

https://www.zerohedge.com/covid-19/rate-adver...r-flu-shot
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EDB Bolsters AI Governance With Strategic Expertise

Updated Category News Views 196

EDB’s Strategic Move in AI Governance EnterpriseDB (EDB) is throwing some serious weight behind their AI governance strategy by bringing in top-notch talent from CMRD. The buzz? This team didn’t just descend in a parachute—they already have their fingerprints all over the audit infrastructure of EDB’s governance solution. Now, they're officially joining EDB’s...

Continue Reading
AI Use Hits 93% in Health Systems' Digital Shift

Updated Category News Views 19

Healthcare's AI Surge: Jumping the Adoption Hurdle The digital health landscape isn't just humming along—it's hitting high gear. AI, once the shiny toy in innovation's toolkit, is now a fixture in 93.2% of healthcare systems according to CHIME's latest findings. For anyone keeping score, that's a hefty leap and paints a picture where AI isn't just in the game, it's...

Continue Reading
SEMIFIVE Soars on Record-Breaking Order Spike

Updated Category News Views 59

SEMIFIVE's Order Surge: An Investor's Triumph Throw the confetti and pop the champagne, SEMIFIVE just shellacked its previous records with a blistering 437% year-over-year increase in new orders for the third quarter of 2026. We're talking a leap from KRW 33.2 billion last year to a staggering KRW 178.4 billion this time around. These aren't just numbers on a spreadsheet;...

Continue Reading
Biodiversity Monitoring Poised for $11.39 Billion Boom

Updated Category News Views 85

A Billion-Dollar Market on the Rise Picture this: you're watching the world make a monumental shift towards sustainability in real-time. The biodiversity monitoring market is on a gallop, poised to grow from a modest USD 7.17 billion in 2026 to a hearty USD 11.39 billion by 2031. That's a CAGR of 9.7%—a pace that soothes the nerves of any investor weary of the whims of...

Continue Reading
CINIE 2026: Nuclear Energy Titans Gather in Shenzhen

Updated Category News Views 82

Setting the Stage for CINIE 2026 Alright, folks, let's dive headfirst into the whirlwind that's brewing over in Shenzhen, China. The 5th China Nuclear Energy High-Quality Development Conference, alongside the Shenzhen International Nuclear Energy Industry Innovation Expo—better known in acronym land as CINIE 2026—is gearing up to be one for the books. Taking over a...

Continue Reading
Lucas Bols Wins Spirit Brand of the Year 2026

Updated Category News Views 198

Lucas Bols: A Legacy Crowned A 450-year-old legacy finally gets its due with the Lucas Bols Company snagging the "Spirit Brand of the Year" title from Wine Enthusiast. This ain’t just another pat on the back; it's a serious nod to a brand that’s been laying down the cocktail foundation long before some countries even existed. Across the past five centuries, they've...

Continue Reading
Funding Fuels LCH2's Vision for Clean Energy Campus

Updated Category News Views 113

Money Talks: LCH2 Scores Big Again Just when you think it's all talk, they pony up another million bucks. The Lewis County Hydrogen Alliance, otherwise known as LCH2, didn't stop with a decent $400k earmark. Nope, they just went ahead and snagged an additional $1 million from TransAlta Centralia. This ain't chump change—it brings their total grant pile to a solid $1.4...

Continue Reading
Hybrid Bonding Market Shooting to $2.45 Billion by 2033

Updated Category News Views 28

Hybrid Bonding: The Future of Semiconductor Interconnects? Mark these words: Hybrid bonding isn't just another tech trend—it’s morphing into a billion-dollar juggernaut, my friend. With the latest numbers from MarketsandMarkets™, we see a potential leap from USD 0.38 billion in 2026 to a staggering USD 2.45 billion by 2033. We'll be seeing an eye-popping CAGR of...

Continue Reading
Taiwan's T+ MedIC: Launching AI-Driven Health Tech

Updated Category News Views 18

A New Wave of Healthcare Innovation in Taiwan Listen up, because something interesting is brewing in Taiwan's healthcare sector. Not the kind of shenanigans cooked up by Wall Street, but a genuine shot at transforming patient care. The T+ MedIC Medical Innovation Accelerator has just crowned its first winners, and we're talking a whole new level of medical tech...

Continue Reading
Compass, Inc. Faces Class Action After Merger Fallout

Updated Category News Views 124

Compass Merger Sparks Lawsuit Slammed with a class action, Compass, Inc. (NYSE: COMP) finds itself tangled in a mess. Earlier this year, things were looking up for Compass when they merged with Anywhere Real Estate Inc., but it seemed like a beautiful day in the neighborhood until some dark clouds appeared. This whole debacle went down thanks to allegedly misleading...

Continue Reading

Top 5 Most Recently Viewed Articles

Recognizing Community Heroes: The Moi Rewards Campaign in Ontario

Updated Category News Views 182

Recognizing Community Heroes: The Moi Rewards Campaign in Ontario Toronto – METRO Inc.’s Moi Rewards is on a mission to acknowledge and reward the incredible contributions of everyday Ontarians. As part of this initiative, METRO is launching a campaign aimed at celebrating individuals who are making a significant difference in their communities, encouraging...

Continue Reading
FIBRA Prologis Secures $500 Million Through Senior Notes Issuance

Updated Category News Views 162

Significant Capital Raise by FIBRA Prologis FIBRA Prologis, a prominent player in the industrial real estate sector, has successfully completed the issuance of USD$500 million in Senior Notes. These notes, which carry an interest rate of 5.625% and are due in 2038, represent a significant step in enhancing FIBRA Prologis' capital structure for future investments....

Continue Reading
Vista Residential Partners Launches New Apartment Community Project

Updated Category News Views 226

Vista Residential Partners Launches New Apartment Community Project Vista Residential Partners has recently taken an exciting step forward in the multifamily housing sector with their groundbreaking ceremony for Mill Grove Vista. This ambitious project will feature 304 Class A garden-style apartments designed to enhance community living. Strategic planning and design have...

Continue Reading
Brazilian Stock Market Experiences Notable Decline

Updated Category News Views 142

Brazilian Stock Market Experiences Notable Decline The Brazilian stock market faced a downward trend recently, prompting noteworthy concerns among investors. As the week progressed, various sectors struggled, particularly in basic materials, consumer goods, and industrials, leading to a significant impact on the Bovespa index. Market Overview At the final trading session...

Continue Reading
Vincere Biosciences Receives $5M Grant for Parkinson's Research

Updated Category News Views 219

Vincere Biosciences Secures Funding to Propel Parkinson's Research Vincere Biosciences has recently achieved a significant milestone, receiving a substantial grant from The Michael J. Fox Foundation for Parkinson's Research. This funding, amounting to $5 million, is directed toward enhancing the development of their promising USP30 inhibitors designed to combat...

Continue Reading